ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,871, issued on April 21, was assigned to UCL Business LTD (London).
"Molecular signature" was invented by Vitor Hugo De Sousa Teixeira (London), Samuel Janes (London), Christodoulos P. Pipinikas (London) and Adam James Pennycuick (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of identifying a pre-invasive lung lesion in an individual that will progress to an invasive lung cancer involving determining the presence or absence of a molecular signature.The present invention also relates to a method of treating a pre-invasive lung lesion and/or treating and/or preventing an invasive lung cancer in an ind...